MetLife, Inc. (MET) Becoming A Gem To Institutional Investors?

MetLife, Inc. (NYSE:MET) went up to recover about -0.75% since recording its record low price of $38.53. The stock experienced -1.01% slump, arriving at $38.24 on 12/24/2018. During the day, the stock price traveled from $37.91 to $39.2355. This company shares are 36.4% off its target price of $52.16 and the current market capitalization stands at $38.35B. The recent change has given its price a -10.05% deficit over SMA 50 and -30.74% deficit over its 52-week high. The stock witnessed -11.05% declines, -20.86% declines and -15.4% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found MET’s volatility during a week at 3.69% and during a month it has been found around 3.14%.

MetLife, Inc. (MET) Top Holders

Institutional investors currently hold around $29.88 billion or 79.2% in MET stock. Look at its top three institutional owners. Blackrock Inc. owns $2.77 billion in MetLife, Inc., which represents roughly 7.22% of the company’s market cap and approximately 9.27% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 66,338,445 shares of the stock are valued at $2.56 billion. The third largest holder is Fmr Llc, which currently holds $2.03 billion worth of this stock and that ownership represents nearly 5.29% of its market capitalization.

MetLife, Inc. 13F Filings

At the end of September reporting period, 411 institutional holders increased their position in MetLife, Inc. (NYSE:MET) by some 33,196,869 shares, 526 decreased positions by 40,623,556 and 161 held positions by 699,569,800. That puts total institutional holdings at 773,390,225 shares, according to SEC filings. The stock grabbed 68 new institutional investments totaling 3,204,023 shares while 78 institutional investors sold out their entire positions totaling 3,425,906 shares.

MetLife, Inc. (NYSE:MET) Insider Trades

Multiple company employees have indulged in significant insider trading. MetLife, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Gutierrez Carlos M has acquired 6,400 shares of MetLife, Inc. (MET) in trading session dated Dec. 17, 2018. These shares are worth $249,856 and were traded at $39.04 each. The SEC filing shows that Kandarian Steven A performed a sale of 42,805 shares. The Chairman, President & CEO disposed these shares by way of transaction on Aug. 27, 2018. The company’s shares were given away at $47.03 per share worth to an income of some $2,013,119 on account of Kandarian Steven A.

Chairman, President & CEO, Kandarian Steven A, sold 85,683 common shares of MetLife, Inc. (MET) in the open market. In a transaction dated Aug. 21, 2018, the shares were put up for sale at an average price of $46.93, raking in a sum of $4,021,103. After this sale, 508,572 common shares of MET are directly owned by the insider, with total stake valued at $19,447,793.

In the transaction dated May. 09, 2018, the great number of shares acquired came courtesy the Director; Hassell Gerald L added a total of 10,000 shares at an average price of $46.18, amounting to approximately $461,800. The insider now directly owns 11,047 shares worth $422,437.

MetLife, Inc. (MET) Analyst Guide

Several analysts have released their opinion on MetLife, Inc. (NYSE:MET), with 4 analysts believing it is a strong buy. Whereas 8 of them predict the stock is a hold. Also, there are 6 buy, 0 sell and 1 strong sell ratings, collectively assigning a 2.37 average brokerage recommendation.